| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2006 | US20060148831 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 07/06/2006 | US20060148830 Lpa receptor antagonist |
| 07/06/2006 | US20060148829 Means for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti |
| 07/06/2006 | US20060148828 Combination comprising a CDK inhibitor and a topoisomerase 1 inhibitor for the treatment of cancer and other proliferative diseases |
| 07/06/2006 | US20060148827 administering adenosine receptor antagonist; side effect reduction; Parkinson's disease |
| 07/06/2006 | US20060148826 Stable aqueous solutions of risperidone and methods for their preparation |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148823 Tricyclic delta -opioid modulators; 10-(1-Benzyl-piperidin-4-yl)-6-hydroxy-10H-phenoxazine-3-carboxylic acid diethylamide; immunosuppressants, antiinflammatory agents, depression, Parkinson's disease; reduced side effects; veterinary composition to treat mild to severe pain in warm-blooded animals |
| 07/06/2006 | US20060148822 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148820 Chroman derivatives and uses thereof |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148818 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders |
| 07/06/2006 | US20060148817 Pyrazole compounds |
| 07/06/2006 | US20060148816 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/06/2006 | US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148813 administering a therapeutically effective amount of ((3S,5S)-5-(3-cyclopentyloxy-4-methoxy-phenyl)-3-(3-methyl-benzyl)-piperidin-2-one (HT0712) or rolipram to an animal in need of treatment of a cognitive deficit associated with Rubinstein-Taybi syndrome; delirium; dementia; Alzheimer's disease |
| 07/06/2006 | US20060148812 4-cyano-1H-imidazole-2-carboxylic acid {2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl}-amide; protein tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 07/06/2006 | US20060148811 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 07/06/2006 | US20060148810 Treatment of amm |
| 07/06/2006 | US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester |
| 07/06/2006 | US20060148808 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 07/06/2006 | US20060148807 Pyrrolo[1,2b]pyridazine compounds and their uses |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148805 Opthalmic compositions for treating ocular hypertension |
| 07/06/2006 | US20060148804 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/06/2006 | US20060148803 Substituted peptides useful in the treatment of alzheimer's disease |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148801 Anti-tumor compounds |
| 07/06/2006 | US20060148800 e.g. 2-(2-methoxy-4-propylcarbamoyl-phenylamino)-4-chloro-5-trifluoromethyl-pyrimidine; polo-like kinase inhibitor; cyclin-dependent and Aurora kinases inhibitor; antiproliferative agent |
| 07/06/2006 | US20060148799 Substituted p-phenyl carbamates |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148797 Benzoyl-tetrahydropiperidine derivatives |
| 07/06/2006 | US20060148796 6-Substituted imidazopyrazines |
| 07/06/2006 | US20060148795 Novel compounds for use in weight loss and appetite suppression in humans |
| 07/06/2006 | US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity |
| 07/06/2006 | US20060148793 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148790 Benzodiazepine cgrp receptor antagonists |
| 07/06/2006 | US20060148789 Novel diazabicyclic aryl derivatives |
| 07/06/2006 | US20060148788 Pyrrolobenzodiazepines |
| 07/06/2006 | US20060148787 compositions are disclosed comprising betahistine, or a salt thereof, and olanzapine in amounts effective to reduce the weight gain associated with olanzapine administration; slow-release dosage form |
| 07/06/2006 | US20060148786 Medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| 07/06/2006 | US20060148785 Medicine for treating gastrointestinal disorder including fecal incontinence |
| 07/06/2006 | US20060148784 Medicine for treating gastrointestinal disorder in a non-human mammal |
| 07/06/2006 | US20060148783 Method and medicine for treating gastrointestinal disorder including fecal incontinence |
| 07/06/2006 | US20060148782 Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both |
| 07/06/2006 | US20060148781 Method and medicine for treating gastrointestinal disorder in a non-human mammal |
| 07/06/2006 | US20060148780 Diazepanes derivatives useful as ifa inhibitors |
| 07/06/2006 | US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives |
| 07/06/2006 | US20060148778 Ultraviolet radiation absorbers; such as 1 azaspiro(3,5)nona-5,8-dione derivative substituted in first position with oxy, thio or carbonyl group |
| 07/06/2006 | US20060148777 1,5-Bis-((2-dimethylamino-N-oxide)ethyl)amino)-4,8-dihydroxyanthracene-9,10-dione; DRAQ5 dyes;analyzing cells/biological material and detecting emitted fluorescence signal; cell permeant DNA-interactive agents providing a fluorescence signature into the infra red spectra; red-line emitting lasers |
| 07/06/2006 | US20060148776 Drug formulations having long and medium chain triglycerides |
| 07/06/2006 | US20060148775 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis. |
| 07/06/2006 | US20060148774 Hypoglycemic agent |
| 07/06/2006 | US20060148773 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; benign prostatic hyperplasa; cardiovascular disorders; acne |
| 07/06/2006 | US20060148772 Combination |
| 07/06/2006 | US20060148771 Medicinal compounds |
| 07/06/2006 | US20060148770 Combinations for the treatment of rheumatoid arithritis |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148768 Vitamin d3 lactone derivatives |
| 07/06/2006 | US20060148767 Use of acyl salicylates as heat shock inducers |
| 07/06/2006 | US20060148766 Composition comprising minocycline as an effective component for prevention and treatment of dementia, and learning and memory impairments |
| 07/06/2006 | US20060148765 7-Substituted fused ring tetracycline compounds |
| 07/06/2006 | US20060148764 5-phenypyrimidines their preparation compositions comprising them and their use |
| 07/06/2006 | US20060148763 Compounds and methods for regulating triglyceride levels |
| 07/06/2006 | US20060148762 Stable in humid environments; bone resorption disorders; mixing and heating an aqueous solution of the salt hydrate with isopropanol and crystallizing during slow cooling |
| 07/06/2006 | US20060148761 Lipids |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148759 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/06/2006 | US20060148758 Method for blood glucose control in a mammal by N-acylated glucosamines |
| 07/06/2006 | US20060148757 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof |
| 07/06/2006 | US20060148756 Amphiphilic macrocyclic derivatives and their analogues |
| 07/06/2006 | US20060148755 Regimens for intra-articular viscosupplementation |
| 07/06/2006 | US20060148754 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 07/06/2006 | US20060148753 Dihydropyrimidine dehydrogenase (DPD) inhibitors; 5-fluorouracil; anticancer |
| 07/06/2006 | US20060148752 Method of treating soild tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148744 Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke |
| 07/06/2006 | US20060148738 Preventive for adhesion following abdominal surgery |
| 07/06/2006 | US20060148736 Device for assaying polymorphisms of gene xpd/ercc2 for the correct administration of chemotherapy for lung cancer |
| 07/06/2006 | US20060148733 Composition containing total triterpenoid saponins extracted from bamboo, and the preparation method and use thereof |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148731 11,12-Lactone bicyclolides |
| 07/06/2006 | US20060148730 Method of treating tuberculosis |
| 07/06/2006 | US20060148729 such as 4'-epi-O-(Tetrahydro-pyran-2-yl)-avermectin B1 monosaccharide and isomers, used as pesticides |
| 07/06/2006 | US20060148728 Novel podophyllotoxin compositions |
| 07/06/2006 | US20060148727 Folate based composition for neurological and cognitive applications |
| 07/06/2006 | US20060148726 Pharmaceutical compositions comprising flavonoids and menthol |
| 07/06/2006 | US20060148725 Selective 11beta HSD inhibitors and methods of use thereof |
| 07/06/2006 | US20060148724 Genipin derivatives and uses thereof |
| 07/06/2006 | US20060148723 Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 07/06/2006 | US20060148722 Novel lincomycin derivatives possessing antibacterial activity |
| 07/06/2006 | US20060148721 Combination therapy for the treatment of dyslipidemia |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148701 Methyl or 2-propyl ester; acute respiratory distress syndrome, pneumonia, bronchitis, meconim aspiration syndrome, cystic fibrosis |